← Open Payments lookup

JESSICA NAPIER: Open Payments

NPI 1720674187 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,659 in 122 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $888 · 2025 $2,659

Food & beverage: $2,548Education: $111
CompanyPaymentsAmount
ABBVIE INC.35$588
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$433
Neurocrine BioSciences, Inc.13$410
Teva Pharmaceuticals USA, Inc.13$376
Alkermes, Inc.13$257
E.R. Squibb & Sons, L.L.C.5$214
Janssen Pharmaceuticals, Inc5$115
Takeda Pharmaceuticals U.S.A., Inc.4$91
Vanda Pharmaceuticals Inc.4$90
Bausch Health US, LLC1$23

Products named: VRAYLAR, CAPLYTA, INGREZZA, ARISTADA, COBENFY, AUSTEDO XR, UZEDY, INVEGA SUSTENNA.

Industry payments across AZ — which companies pay providers there.